<Disease><Name>METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE</Name><Synonym>VITAMIN B12 METABOLIC DEFECT WITH METHYLMALONICACIDEMIA AND HOMOCYSTINURIA</Synonym><OMIM><Number>277400</Number><URL>http://omim.org/entry/277400</URL></OMIM><Orphanet><Number>79282</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=79282</URL></Orphanet><Protein><Number>methylmalonyl-CoA mutase, methionine synthase, inability of the cell to convert Cbl to both of its active forms (MeCbl, AdoCbl)</Number><URL>http://www.uniprot.org/uniprot/Q9Y4U1</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>1p34.1</Gene><ICD>E72.1</ICD><Summary>rare (1:100.000, &gt;550 cases) ;autosomal recessive ;mutation in the MMACHC gene;Methylmalonic aciduria and homocystinuria, cblC type is the most common inborn error of vitamin B(12) (cobalamin) metabolism [Lerner-Ellis JP 2006, De Simone L 2018].;partial ;CblC;-type MMA can onset with severe metabolic aHUS [Chen M et al. 2017]</Summary><Symptoms><symtomp><id>2074</id><symptom>Amino acids, plasma</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2347</id><symptom>anemia</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2151</id><symptom>atrial septal defect</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2323</id><symptom>behavior, abnormal or bizarre, confusion / behaviour, abnormal or bizarre</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1952</id><symptom>behavior, self-mutilating or destructive / behaviour, self-mutilating or destructive</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3158</id><symptom>cardiac involvement, defects or anomalies</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2104</id><symptom>cardiomyopathy</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2226</id><symptom>cerebral atrophy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3165</id><symptom>dementia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3819</id><symptom>developmental delay</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1982</id><symptom>diarrhea</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>4107</id><symptom>Encephalopathic crisis, acute</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1969</id><symptom>extrapyramidal signs</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2254</id><symptom>glossitis</symptom><category>HEAD</category></symtomp><symtomp><id>2449</id><symptom>heart involvement</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2274</id><symptom>hematuria</symptom><category>GENERAL TOPICS | GENITOURINARY TRACT</category></symtomp><symtomp><id>2026</id><symptom>hemolysis</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>3432</id><symptom>Hemolytic-uremic-syndrome</symptom><category>GENITOURINARY TRACT | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>1960</id><symptom>hydrocephalus</symptom><category>HEAD | NERVOUS SYSTEM</category></symtomp><symtomp><id>2356</id><symptom>hydrops fetalis</symptom><category>GENERAL TOPICS | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2468</id><symptom>impaired visual acuity</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1953</id><symptom>lethargy, drowsiness, apathy</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1998</id><symptom>liver involvement or dysfunction</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3863</id><symptom>low birthweight (small for gestational age)</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>4070</id><symptom>maculopathy</symptom><category>EYES</category></symtomp><symtomp><id>3959</id><symptom>megaloblastic anemia</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2065</id><symptom>metabolic acidosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>1917</id><symptom>neurological deterioration / neurologic deterioration</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2038</id><symptom>neutropenia (decreased neutrophils)</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>1723</id><symptom>nystagmus</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1915</id><symptom>onset, adulthood / adoulthood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2554</id><symptom>onset, fetus / fetal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3783</id><symptom>onset, variable age</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2089</id><symptom>Organic acids, urine</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1958</id><symptom>psychosis</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3696</id><symptom>pulmonary hypertension</symptom><category>CARDIOVASCULAR SYSTEM | LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>2461</id><symptom>renal failure, acute/chronic</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>1730</id><symptom>retinal or macular degeneration</symptom><category>EYES</category></symtomp><symtomp><id>2375</id><symptom>retinopathy</symptom><category>EYES</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2006</id><symptom>skin defects</symptom><category>GENERAL TOPICS | SKIN</category></symtomp><symtomp><id>1700</id><symptom>small for gestational age (SGA), intrauterine growth retardation (IUGR)</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2253</id><symptom>stomatitis / stomatitits</symptom><category>HEAD</category></symtomp><symtomp><id>2034</id><symptom>thromboembolism</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3199</id><symptom>thrombopenia, thrombocytopenia</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1980</id><symptom>vomiting</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>1600</id><name>Betaine</name><specimen>urine</specimen><value>normal/inc</value><min>2.70</min><max>24.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1651</id><name>Methionine</name><specimen>urine</specimen><value>normal/inc</value><min>0.50</min><max>2.50</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1661</id><name>Methylmalonic acid</name><specimen>urine</specimen><value>increased</value><min>0.70</min><max>3.50</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1758</id><name>Betaine</name><specimen>urine</specimen><value>normal/inc</value><min>44.00</min><max>1200.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1769</id><name>Homocysteine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>170.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1774</id><name>Methionine</name><specimen>urine</specimen><value>increased</value><min>13.00</min><max>22.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1815</id><name>Methylmalonic acid</name><specimen>urine</specimen><value>increased</value><min>10.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1879</id><name>Methionine</name><specimen>plasma</specimen><value>normal/dec</value><min>16.00</min><max>23.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1880</id><name>Methionine</name><specimen>plasma</specimen><value>normal/dec</value><min>14.00</min><max>34.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1882</id><name>Methionine</name><specimen>urine</specimen><value>normal/dec</value><min>2.00</min><max>16.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1956</id><name>Methionine</name><specimen>plasma</specimen><value>normal/dec</value><min>9.00</min><max>45.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1957</id><name>Methionine</name><specimen>plasma</specimen><value>normal/dec</value><min>13.00</min><max>41.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>1490</id><name>Betaine</name><specimen>urine</specimen><value>normal/inc</value><min>260.00</min><max>913.00</max><unit>mmol/mol creatinine</unit><age>newborn 1-7d</age><method /><comment /></metabolite><metabolite><id>485</id><name>Hemoglobine</name><specimen>blood</specimen><value>normal/dec</value><min>12.00</min><max>20.00</max><unit>g/dl</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>693</id><name>Hemoglobine</name><specimen>blood</specimen><value>normal/dec</value><min>12.00</min><max>15.00</max><unit>g/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1007</id><name>Hemoglobine</name><specimen>blood</specimen><value>normal/dec</value><min>9.00</min><max>14.00</max><unit>g/dl</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>461</id><name>Homocysteine</name><specimen>urine</specimen><value>increased</value><min>4.70</min><max>10.30</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1528</id><name>Homocysteine</name><specimen>urine</specimen><value>increased</value><min>0.20</min><max>3.70</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>186</id><name>Homocysteine</name><specimen>serum</specimen><value>increased</value><min>4.80</min><max>7.40</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1391</id><name>Homocysteine</name><specimen>serum</specimen><value>increased</value><min>4.90</min><max>11.60</max><unit>&#181;mol/l</unit><age>adult, female</age><method /><comment /></metabolite><metabolite><id>1392</id><name>Homocysteine</name><specimen>serum</specimen><value>increased</value><min>5.90</min><max>15.30</max><unit>&#181;mol/l</unit><age>adult, male</age><method /><comment /></metabolite><metabolite><id>1393</id><name>Homocysteine</name><specimen>serum</specimen><value>increased</value><min>4.30</min><max>9.90</max><unit>&#181;mol/l</unit><age>adolescent, male</age><method /><comment /></metabolite><metabolite><id>1394</id><name>Homocysteine</name><specimen>serum</specimen><value>increased</value><min>3.30</min><max>7.20</max><unit>&#181;mol/l</unit><age>adolescent, female</age><method /><comment /></metabolite><metabolite><id>1395</id><name>Homocysteine</name><specimen>serum</specimen><value>increased</value><min>3.50</min><max>4.10</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>1881</id><name>Methionine</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>17.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1494</id><name>Methionine</name><specimen>plasma</specimen><value>normal/dec</value><min>11.00</min><max>31.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>760</id><name>Methionine</name><specimen>urine</specimen><value>normal/dec</value><min>5.00</min><max>29.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1510</id><name>Methionine</name><specimen>urine</specimen><value>normal/dec</value><min>7.00</min><max>27.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1511</id><name>Methionine</name><specimen>urine</specimen><value>normal/dec</value><min>6.00</min><max>29.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>699</id><name>Methionine</name><specimen>plasma</specimen><value>normal/dec</value><min>11.00</min><max>30.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1161</id><name>Methionine</name><specimen>plasma</specimen><value>normal/dec</value><min>10.00</min><max>60.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1162</id><name>Methionine</name><specimen>plasma</specimen><value>normal/dec</value><min>11.00</min><max>31.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>1288</id><name>Methionine</name><specimen>plasma</specimen><value>normal/dec</value><min>6.00</min><max>46.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>1289</id><name>Methionine</name><specimen>plasma</specimen><value>normal/dec</value><min>9.00</min><max>59.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>8</id><name>Methylmalonic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>520</id><name>Methylmalonic acid</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>11.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>521</id><name>Methylmalonic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>79.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>522</id><name>Methylmalonic acid</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>25.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>523</id><name>Methylmalonic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>1418</id><name>Methylmalonic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>79.00</max><unit>mmol/mol creatinine</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>392</id><name>Methylmalonic acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>0.20</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>GCMS</method><comment /></metabolite><metabolite><id>393</id><name>Methylmalonic acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit /><age>child</age><method /><comment /></metabolite><metabolite><id>1096</id><name>Protein</name><specimen>urine</specimen><value>increased</value><min>50.00</min><max>80.00</max><unit>mg/24 hr</unit><age>no data</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>6615</id><title>European Network and Registry for Homocystinurias and Methylation Defects (E-HOD)</title><author /><journal /><year>9999</year><book /><volume>0</volume><number>0</number><pages /><co_aut /></literature><literature><id>7483</id><title>Generation of a Human iPSC line (SDQLCHi021-A) from a patient with methylmalonic acidemia cblC type carrying compound heterozy</title><author>Guan J,</author><journal>Stem Cell Res</journal><year>2020</year><book /><volume>43</volume><number>0</number><pages>101709</pages><co_aut>et al.</co_aut></literature><literature><id>8050</id><title>Diagnostic Challenges Using a 2-Tier Strategy for Methylmalonic Acidurias: Data from 1.2 Million Dried Blood Spots</title><author>Weiss K,</author><journal>Ann Nutr Metab</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages>1-9</pages><co_aut>et al.</co_aut></literature><literature><id>8052</id><title>Pulmonary hypertension in late-onset Methylmalonic Aciduria and Homocystinemia: a case report</title><author>Wen L-Y,</author><journal>BMC Pediatr</journal><year>2020</year><book /><volume>20</volume><number>1</number><pages>243</pages><co_aut>et al.</co_aut></literature><literature><id>6614</id><title>Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: Data from th</title><author>Huemer M,</author><journal>J Inherit Metab Dis</journal><year>2019</year><book /><volume>42</volume><number>2</number><pages>333-352</pages><co_aut>et al.</co_aut></literature><literature><id>7484</id><title>High-dose hydroxocobalamin achieves biochemical correction and improvement of neuropsychiatric deficits in adults with late onset cobalamin C deficiency</title><author>Higashimoto T,</author><journal>JIMD Rep</journal><year>2019</year><book /><volume>51</volume><number>1</number><pages>17-24</pages><co_aut>et al.</co_aut></literature><literature><id>7485</id><title>Mutation spectrum of MMACHC in Chinese pediatric patients with cobalamin C disease: A case series and literature review</title><author>Wang C,</author><journal>Eur J Med Genet</journal><year>2019</year><book /><volume>62</volume><number>10</number><pages>103713</pages><co_aut>et al.</co_aut></literature><literature><id>7486</id><title>Isolated subacute combined degeneration in late-onset cobalamin C deficiency in children: Two case reports and literature review</title><author>Cui J,</author><journal>Medicine (Baltimore)</journal><year>2019</year><book /><volume>98</volume><number>39</number><pages>e17334</pages><co_aut>et al.</co_aut></literature><literature><id>6387</id><title>Hydrocephalus in cblC type methylmalonic acidemia</title><author>Zhang K,</author><journal>Metab Brain Dis</journal><year>2018</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6393</id><title>Molecular genetic characterization of cblC defects in 126 pedigrees and prenatal genetic diagnosis of pedigrees with combined methylmalonic aciduria and homocystinuria</title><author>Hu S,</author><journal>BMC Med Genet</journal><year>2018</year><book /><volume>19</volume><number>1</number><pages>154</pages><co_aut>et al.</co_aut></literature><literature><id>6394</id><title>Favorable course of previously undiagnosed Methylmalonic Aciduria with Homocystinuria (cblC type) presenting with pulmonary hypertension and aHUS in a young child: a case repo</title><author>De Simone L,</author><journal>Ital J Pediatr</journal><year>2018</year><book /><volume>44</volume><number>1</number><pages>90</pages><co_aut>et al.</co_aut></literature><literature><id>6397</id><title>[Heterogeneous phenotypes, genotypes, treatment and prevention of 1 003 patients with methylmalonic acidemia in the mainland of</title><author>Liu Y,</author><journal>Zhonghua Er Ke Za Zhi</journal><year>2018</year><book /><volume>26</volume><number>6</number><pages>414-420</pages><co_aut>et al.</co_aut></literature><literature><id>6398</id><title>Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: data from th</title><author>Huemer M,</author><journal>J Inherit Metab Dis</journal><year>2018</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>5313</id><title>Milder clinical and biochemical phenotypes associated with the c.482G</title><author>Almannai M,</author><journal>Mol Genet Metab</journal><year>2017</year><book /><volume>122</volume><number>1</number><pages>60-66</pages><co_aut>et al.</co_aut></literature><literature><id>5578</id><title>Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency</title><author>Huemer M,</author><journal>J Inherit Metab Dis</journal><year>2017</year><book /><volume>40</volume><number>1</number><pages>21-48</pages><co_aut>et al.</co_aut></literature><literature><id>5718</id><title>Skin lesions in a patient with Cobalamin C disease in poor metabolic control</title><author>Prasun P,</author><journal>J Inherit Metab Dis</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>5747</id><title>Atypical hemolytic uremic syndrome induced by CblC subtype of methylmalonic academia: A case report and literature review</title><author>Chen M,</author><journal>Medicine (Baltimore)</journal><year>2017</year><book /><volume>96</volume><number>43</number><pages>e8284</pages><co_aut>et al.</co_aut></literature><literature><id>5748</id><title>Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity</title><author>Beck BB,</author><journal>Pediatr Nephrol</journal><year>2017</year><book /><volume>32</volume><number>5</number><pages>733-741</pages><co_aut>et al.</co_aut></literature><literature><id>5749</id><title>HUS and atypical HUS</title><author>Jokiranta TS</author><journal>Blood</journal><year>2017</year><book /><volume>129</volume><number>21</number><pages>2847-2856</pages><co_aut /></literature><literature><id>6316</id><title>[Pulmonary arterial hypertension as leading manifestation of methylmalonic aciduria: clinical characteristics and gene testing </title><author>Liu XQ,</author><journal>Beijing Da Xue Xue Bao Yi Xue Ban</journal><year>2017</year><book /><volume>49</volume><number>5</number><pages>768-777</pages><co_aut>et al.</co_aut></literature><literature><id>3804</id><title>Genetic animal models to decipher the pathogenic effects of vitamin B12 and folate deficiency</title><author>Peng L,</author><journal>Biochimie</journal><year>2016</year><book /><volume>126</volume><number>0</number><pages>43-51</pages><co_aut>et al.</co_aut></literature><literature><id>5345</id><title>Methylmalonic Acidemia Diagnosis by Laboratory Methods</title><author>Keyfi F,</author><journal>Rep Biochem Mol Biol</journal><year>2016</year><book /><volume>5</volume><number>1</number><pages>1-14</pages><co_aut>Talebi S, Varasteh AR</co_aut></literature><literature><id>3805</id><title>Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines</title><author>Huemer M,</author><journal>J Inherit Metab Dis</journal><year>2015</year><book /><volume>38</volume><number>6</number><pages>1007-1019</pages><co_aut>et al.</co_aut></literature><literature><id>3806</id><title>Three new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancy</title><author>Huemer M,</author><journal>Orphanet J Rare Dis</journal><year>2014</year><book /><volume>9</volume><number>0</number><pages>161</pages><co_aut>et al.</co_aut></literature><literature><id>7427</id><title>Cobalamin C deficiency in an adolescent with altered mental status and anorexia</title><author>Rahmandar MH,</author><journal>Pediatrics</journal><year>2014</year><book /><volume>134</volume><number>6</number><pages>e1709-1714</pages><co_aut>et al.</co_aut></literature><literature><id>3069</id><title>Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management</title><author>Carrillo-Carrasco N,</author><journal>J Inherit Metab Dis</journal><year>2012</year><book /><volume>35</volume><number>1</number><pages>91-102</pages><co_aut>Chandler RJ, Venditti CP.</co_aut></literature><literature><id>3070</id><title>Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes</title><author>Carrillo-Carrasco N,</author><journal>J Inherit Metab Dis</journal><year>2012</year><book /><volume>35</volume><number>1</number><pages>103-114</pages><co_aut>Venditti CP</co_aut></literature><literature><id>3082</id><title>Different altered pattern expression of genes related to apoptosis in isolated methylmalonic aciduria cblB type and combined with homocystinuria cblC type</title><author>Jorge-Finnigan A,</author><journal>Biochim Biophys Acta</journal><year>2010</year><book /><volume>1802</volume><number>11</number><pages>959-967</pages><co_aut>et al.</co_aut></literature><literature><id>2821</id><title>Fetal dilated cardiomyopathy: an unsuspected presentation of methylmalonic aciduria and hyperhomocystinuria, cblC type</title><author>De Bie I,</author><journal>Prenat Diagn</journal><year>2009</year><book /><volume>29</volume><number>3</number><pages>266-270</pages><co_aut>Nizard SD, Mitchell GA</co_aut></literature><literature><id>2646</id><title>Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type</title><author>Lerner-Ellis JP</author><journal>Nat Genet</journal><year>2006</year><book /><volume>38</volume><number>1</number><pages>93-100</pages><co_aut>et al.</co_aut></literature><literature><id>2647</id><title>Combined methylmalonic aciduria and homocystinuria (cblC): Phenotype-genotype correlations and ethnic-specific observations</title><author>Morel CF</author><journal>Mol Genet Metab</journal><year>2006</year><book /><volume>88</volume><number>4</number><pages>315-321</pages><co_aut>et al.</co_aut></literature><literature><id>2648</id><title>The natural history of retinal degeneration in association with cobalamin C (cbl C) disease</title><author>Schimel AM</author><journal>Ophthalmic Genet</journal><year>2006</year><book /><volume>27</volume><number>1</number><pages>9-14</pages><co_aut>Mets MB</co_aut></literature><literature><id>2653</id><title>Subacute combined degeneration of the spinal cord in cblC disorder despite treatment with B12</title><author>Smith SE</author><journal>Mol Genet Metab</journal><year>2006</year><book /><volume>88</volume><number>2</number><pages>138-145</pages><co_aut>et al.</co_aut></literature><literature><id>2654</id><title>Prenatal and postnatal treatment in cobalamin C defect</title><author>Huemer M</author><journal>J Pediatr</journal><year>2005</year><book /><volume>147</volume><number>4</number><pages>469-472</pages><co_aut>et al.</co_aut></literature><literature><id>1407</id><title>Neuropsychiatric disturbances in presumed late-onset cobalamin C disease</title><author>Roze E</author><journal>Arch Neurol</journal><year>2003</year><book /><volume>60</volume><number>10</number><pages>1457-1462</pages><co_aut>et al.</co_aut></literature><literature><id>1754</id><title>Spectroscopic and computational studies of Co3+-corrinoids: spectral and electronic properties of the B12 cofactors and biologi</title><author>Stich TA</author><journal>J Am Chem Soc. 2003 May 14;125(19):5897-914</journal><year>2003</year><book /><volume>125</volume><number>19</number><pages>5897-5914</pages><co_aut>et al.</co_aut></literature><literature><id>1259</id><title>Cobalamin disorder Cbl-C presenting with late-onset thrombotic microangiopathy</title><author>Van Hove JL</author><journal>Am J Med Genet</journal><year>2002</year><book /><volume>111</volume><number>2</number><pages>195-201</pages><co_aut>et al.</co_aut></literature><literature><id>1408</id><title>Early-onset cobalamin C/D deficiency: epilepsy and electroencephalographic features</title><author>Biancheri R</author><journal>Epilepsia</journal><year>2002</year><book /><volume>43</volume><number>6</number><pages>616-622</pages><co_aut>et al.</co_aut></literature><literature><id>1258</id><title>Long-term outcome in treated combined methylmalonic acidemia and homocystinemia</title><author>Andersson HC</author><journal>Genet Med</journal><year>1999</year><book /><volume>1</volume><number>4</number><pages>146-150</pages><co_aut>Marble M, Shapira E</co_aut></literature><literature><id>841</id><title>Inherited disorders of cobalamin and folate absorption and metabolism</title><author>Rosenblatt DS</author><journal>in Fernandes J, Saudubray JM, van den Berghe (eds): Inborn metabolic diseases, diagnosis and treatment; Berlin, Springer Verlag</journal><year>1996</year><book /><volume>0</volume><number>0</number><pages>247-258</pages><co_aut>Shevell MI</co_aut></literature><literature><id>91</id><title>Inherited disorders of cobalamin transport and metabolism</title><author>Fenton WA</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>0</number><pages>3129-3249</pages><co_aut>Rosenberg LE</co_aut></literature><literature><id>1755</id><title>Clinical and biochemical observations in a patient with combined Pompe disease and cblC mutation</title><author>Wijburg FA</author><journal>Eur J Pediatr</journal><year>1992</year><book /><volume>151</volume><number>2</number><pages>127-131</pages><co_aut>et al.</co_aut></literature><literature><id>92</id><title>Defect in vitamin B-12 relase from lysosomes: newly discribed inborn error of metabolism</title><author>Rosenblatt DS</author><journal>Science</journal><year>1985</year><book /><volume>228</volume><number>0</number><pages>1319-1321</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>